Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 4 Breast Neoplasms 4 Neoplasm Metastasis 3 Lung Neoplasms 3 Triple Negative Breast Neoplasms 2 Multiple Myeloma 2 Lymphoma 2 Glioblastoma 2 Colorectal Neoplasms 2 Stroke 1 Recurrence 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Neurologic Manifestations 1 Myelodysplastic Syndromes 1 Motor Activity 1 Melanoma 1 Margins of Excision 1 Malignant Solid Neoplasm 1 Malignant Female Reproductive System Neoplasm 1 Localized Head and Neck Carcinoma 1 Leukemia, Myeloid, Acute 1 Leukemia 1 Inflammatory Breast Neoplasms 1 Hematologic Neoplasms 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Depression 1 Communication 1

Interventions

Bupivacaine 2 Acetaminophen 2 engage 8200 1 Transdermal Patch 1 Transcutaneous Electric Nerve Stimulation 1 Telemedicine 1 STAMP-I protocol 1 Radiosurgery 1 Palliative Care 1 Oxycodone 1 Methods 1 Ketorolac 1 Ketoprofen 1 Ketamine 1 Capsaicin 1 Botulinum Toxins, Type A 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Agnosia × Palliative Care × 90 days × Clear all

NCT06555588 2026-03-16

Engage

Duke University

Phase NA Recruiting

Agnosia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡